Paper Title
Use of Injectable, Liquid-Platelet rich fibrin(PRF) as an Non-Surgical Adjuvant in Accelerated Periapical Healing of Non Vital tooth: A Case Report
Article Identifiers
Registration ID: IJNRD_187281
Published ID: IJNRD2302169
: http://doi.one/10.1729/Journal.33086
Authors
Keywords
PRF. Non vital tooth, periapical lesion, Triple antibiotic paste (TAP)
Abstract
Regenerative endodontics is the boon today. Different types of Regenerative methods have been used in the recent past including inducing bleeding at the periapical regions. So that induced blood clot may lead to formation of bone at the periapex. Use of blood products in form of liquid PRF shows significant resolution of periapical symptoms and signs. This case report focuses on the safest experimental protocol where product of autologous blood -liquid PRF which has maximum growth factor can be used for resolution of periapical radiolucency, that also in comparatively less average time The patient’s main concerns were the blackish discolouration and broken tooth and important clinical findings tooth were tender on percussion. The primary diagnoses of Non vital tooth with periapical radiolucency was made, nonsurgical endodontics were the preferred interventions, and research worth treatment outcomes were found. Liquid or I-PRF shows a promise in early periapical radiolucency resolution and prompt signs of radiographic barrier formation at periapex.
Downloads
How To Cite (APA)
DR. NAMRATA PANDIT RATHOD , DR.VIJAYATA SINGH, DR. YAJUVENDRA SINGH HADA , DR. ABHISHEK MEHTA, & ABHISHEK PARASIYA (February-2023). Use of Injectable, Liquid-Platelet rich fibrin(PRF) as an Non-Surgical Adjuvant in Accelerated Periapical Healing of Non Vital tooth: A Case Report . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(2), b702-b709. http://doi.one/10.1729/Journal.33086
Issue
Volume 8 Issue 2, February-2023
Pages : b702-b709
Other Publication Details
Paper Reg. ID: IJNRD_187281
Published Paper Id: IJNRD2302169
Downloads: 000122254
Research Area: Medical Science
Author Type: Indian Author
Country: Kota, Rajasthan, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2302169.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2302169
Crossref DOI: http://doi.one/10.1729/Journal.33086
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
